LexAurum Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,648
Closed -$340K 313
2024
Q1
$340K Buy
2,648
+662
+33% +$85K 0.09% 204
2023
Q4
$205K Buy
+1,986
New +$205K 0.05% 275